The addition of linagliptin to stable insulin treatment improves glycemic control without increasing the risk for clinically important hypoglycemia among older individuals with type 2 diabetes, randomized trial findings suggest.
A telephone-delivered, collaborative goal-setting intervention can significantly reduce depressive symptoms relative to usual care in people with uncontrolled diabetes and clinically significant depression, research shows.
An offline, smartphone-based, nonmydriatic retinal imaging system accurately detects referable diabetic retinopathy when used by minimally trained operators in a point of care setting, show data from a pilot study carried out in India.
Infants born to mothers with gestational diabetes treated with metformin have lower birthweight, but experience accelerated postnatal growth and have higher BMI in childhood, compared with those whose mothers were treated with insulin, suggest findings from a meta-analysis.
People who undergo bariatric surgery have a lower long-term risk for mortality, but a higher risk for adverse events such as gastrointestinal and nutritional disorders, compared with those who do not undergo surgery, researchers report.
Patients initiating a flexible combination of basal insulin plus a glucagon-like peptide-1 receptor agonist have similar improvements in glycemic control to those initiating a fixed combination, but with greater weight loss, real-world study data show.
Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.
Findings from the SAVOR-TIMI 53 trial suggest that metformin treatment reduces cardiovascular and all-cause mortality but not nonfatal cardiovascular disease events, but a meta-analysis points to wider benefits.
Achieving very low levels of low-density lipoprotein cholesterol while on statin treatment may reduce the risk for cardiovascular disease in people with type 2 diabetes and metabolic dyslipidemia, suggest the results of a large observational study.
The risk for severe urinary tract infections among people with type 2 diabetes in the real-world setting may be no greater with use of sodium-glucose cotransporter 2 inhibitors than with other modern antidiabetes medications, research suggests.
Allocating people with diabetes to one of five previously described data-driven clusters may help to identify those at high immediate risk for developing diabetic neuropathy or non-alcoholic fatty liver disease, say researchers.
Findings from the ESTEEM trial suggest that consuming a Mediterranean-style diet may reduce gestational weight gain and lower the risk for gestational diabetes among pregnant women with metabolic risk factors.
High-dose vitamin D supplementation may slow type 2 diabetes progression by increasing peripheral insulin sensitivity and beta cell function in people at high risk for or newly diagnosed with the condition, randomized trial data show.
Children with type 1 diabetes have worse health outcomes and are more likely to miss school and have special educational needs than their nondiabetic peers, show results of a large study conducted in Scotland.